Eva Feldman

Uses your system voice; voice and rate in settings.

Q5415042Snapshot

≈ 7 min read

Names in other languages

  • astEva Feldman
  • cyEva Feldman
  • DeutschEva Feldman
  • EnglishEva Feldman
  • EspañolEva Feldman
  • FrançaisEva Feldman
  • ItalianoEva Feldman
  • NederlandsEva Feldman

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Eva Lucille Feldman, M.D., Ph.D., is an American physician-scientist known for her work in the field of neurodegenerative diseases. She serves as the James W. Albers Distinguished University Professor of Neurology at the University of Michigan, as well as the Russell N. DeJong Professor of Neurology, Professor of Neurosurgery, and director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine.

Feldman has made contributions to research and clinical care in neurodegenerative diseases. Her primary focus has been on amyotrophic lateral sclerosis (ALS), Alzheimer's disease, cognitive decline, the neurologic complications of diabetes and obesity, as well as how environmental toxins affect the nervous system.

She has conducted research on developing stem cell therapies for the treatment of neurodegenerative diseases. Feldman is on the National Research Council, the operating arm of the National Academies of Science, Engineering and Medicine and the National Academy of Medicine (governing and oversight) Council.

She is also a member of the Association of American Physicians and is a Fellow of the American Association for the Advancement of Science.

Eva Lucille Feldman, M.D., Ph.D., is an American physician-scientist known for her work in the field of neurodegenerative diseases. She serves as the James W. Albers Distinguished University Professor of Neurology at the University of Michigan, as well as the Russell N. DeJong Professor of Neurology, Professor of Neurosurgery, and director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine.

Feldman has made contributions to research and clinical care in neurodegenerative diseases. Her primary focus has been on amyotrophic lateral sclerosis (ALS), Alzheimer's disease, cognitive decline, the neurologic complications of diabetes and obesity, as well as how environmental toxins affect the nervous system.

She has conducted research on developing stem cell therapies for the treatment of neurodegenerative diseases. Feldman is on the National Research Council, the operating arm of the National Academies of Science, Engineering and Medicine and the National Academy of Medicine (governing and oversight) Council.

She is also a member of the Association of American Physicians and is a Fellow of the American Association for the Advancement of Science.

Early life and education

Feldman grew up in Indiana and completed her undergraduate degree in biology and chemistry at Earlham College with honors, followed by an M.S. in zoology at the University Notre Dame. She received her M.D. and Ph.D. at the University of Michigan. She was a Rackham Scholar at Michigan.

She completed her Neurology residency at Johns Hopkins, where she served as Chief Resident and received the Johns Hopkins Award for Medical Teaching and Excellence. She was the first neurologist to receive this award at Hopkins. Feldman then returned to the University of Michigan to complete a neuromuscular disorders fellowship with longtime mentor Dr. James Albers.

Career

In 1988, Feldman became an assistant professor and opened a laboratory in the Department of Neurology at Michigan Medicine, serving as member of the Neuroscience Program and the Michigan Diabetes Research and Training Center. In 1994, she became an associate professor, and in 1998 she joined the faculty of the Cellular and Molecular Biology Program.

In 2000, Feldman became the director of the Juvenile Diabetes Research Foundation Center for the Study of Complications in Diabetes (until 2010), Director of the ALS Center of Excellence at Michigan Medicine, and a fully endowed professor, the Russell N. DeJong Professor of Neurology. In 2005, she was named the Director of Michigan Medicine's Neuropathy Center.

She was appointed the inaugural Director of the A. Alfred Taubman Medical Research Institute in 2007, after U-M received a multimillion-dollar gift from A. Alfred Taubman for its creation. In 2023, she was also given the University of Michigan's most prestigious honor, a Distinguished University Professorship, which was named after her longtime mentor James Albers, M.D., Ph.D.

In 2024, she was named to the faculty of the Department of Neurosurgery at Michigan Medicine. She is a principal investigator or co-Investigator of grants funded by the NIH, including the NIH Director's Transformative Research Award in 2021, as well as grants from the Centers for Disease Control and Prevention's Agency for Toxic Substances and Disease Registry, the Juvenile Diabetes Research Foundation, and private foundations.

Feldman also leads multiple clinical trials focused on understanding and treating neurological disorders, with an emphasis on ALS and neuropathy. Feldman served as President of the Peripheral Nerve Society from 2007 to 2009. She was also the President of the American Neurological Association (ANA) from 2011 to 2013, being only the third woman elected as ANA President in 130 years.

She went on to become the chair of the ANA from 2021–2015. She was the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. She is also the only U-M alumnus to receive both Early and Distinguished Career Achievement Awards from the U-M Medical Alumni Society.

Among her many honors, Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. In 2023, she was appointed to the NAM (governing and oversight) Council and received the Fulton Award from the World Federation of Neurology.

In 2024, Feldman was awarded the Sheila Essey Award for her work in ALS from the American Academy of Neurology, American Brain Foundation, and ALS Association. Also that year, she was part of a special National Academies of Sciences, Engineering and Medicine committee that published "Living With ALS," which set priorities and recommendations to make ALS a livable disease.

In 2025, Feldman received the Award for Distinguished Research in the Biomedical Sciences from the Association of American medical Colleges. Other awards include the Juvenile Diabetes Research Foundation Mary Jane Kugel Award twice (2003 and 2005), the American Diabetes Association Lifetime Achievement Award (2006), the Endocrine Society Gerald D. Aurbach Award for Outstanding Translational Research (2017), and the Peripheral Nerve Society Alan J. Gebhart Prize for Excellence in Peripheral Nerve Research (2019).

Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology, and Journal of Neurology, Neurosurgery and Psychiatry. She has also been featured on numerous media outlets, including CNN, TIME, National Geographic, PBS, and The New York Times, among many more.

Sources

A. Alfred Taubman Medical Research Institute The University of Michigan Health System The American Neurological Association

References

--> PubMed publications

See also

University of Michigan Medicine biography

Text derived from https://en.wikipedia.org/w/index.php?oldid=1345403458 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

19 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.